NCT04275115View on ClinicalTrials.gov

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions
Healthy
Interventions
DRUG

Drug Cocktail

Single oral dose of the cocktail probe substrates (caffeine 200 mg, montelukast 10 mg, midazolam 4 mg)

DRUG

Foliglurax

Foliglurax

DRUG

midazolam iv

Single intravenous (iv) dose of midazolam 0.025 mg/kg

Trial Locations (1)

35000

Biotrial, Rennes

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04275115 - Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects | Biotech Hunter | Biotech Hunter